Dosimetric promise versus cost: critics question proton therapy.
Bryant
B
Furlow
D003362:Cost-Benefit Analysis; D006801:Humans; D009369:Neoplasms / Q000191:economics* / Q000473:pathology / Q000532:radiotherapy*; D061766:Proton Therapy / Q000191:economics*; D011874:Radiometry / Q000191:economics*